Viewing Study NCT06696768


Ignite Creation Date: 2025-12-24 @ 5:51 PM
Ignite Modification Date: 2026-05-28 @ 6:37 AM
Study NCT ID: NCT06696768
Status: RECRUITING
Last Update Posted: 2025-11-17
First Post: 2024-11-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Colorectal Adenocarcinoma View
None Stage III Colorectal Cancer AJCC v8 View
None Stage IV Colorectal Cancer AJCC v8 View
None Unresectable Colorectal Adenocarcinoma View
Keywords: